{"organizations": [], "uuid": "87268195b4007b9ee9611a11c26ab5b7bfda70f2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 18}, "facebook": {"likes": 607, "shares": 607, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XK686_3n9Wo_TOP_20180210182515.jpg", "site_section": "http://www.wsj.com/xml/rss/3_7014.xml", "section_title": "WSJ.com: US Business", "url": "https://www.wsj.com/articles/purdue-pharma-to-stop-promoting-oxycontin-to-u-s-doctors-1518307565", "country": "US", "domain_rank": 387, "title": "Purdue Pharma to Stop Promoting OxyContin to U.S. Doctors", "performance_score": 6, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-11T02:06:00.000+02:00", "replies_count": 0, "uuid": "87268195b4007b9ee9611a11c26ab5b7bfda70f2"}, "author": "Jeanne Whalen", "url": "https://www.wsj.com/articles/purdue-pharma-to-stop-promoting-oxycontin-to-u-s-doctors-1518307565", "ord_in_thread": 0, "title": "Purdue Pharma to Stop Promoting OxyContin to U.S. Doctors", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "purdue pharma", "sentiment": "negative"}, {"name": "purdue pharma lp", "sentiment": "negative"}, {"name": "bloomberg", "sentiment": "none"}, {"name": "purdue", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Privately held drug company Purdue Pharma LP said it would stop promoting OxyContin and other opioids to doctors, 22 years after the painkiller linked to widespread addiction hit the U.S. market.\n\nThe company will continue selling the products, but Purdue’s sales force “will no longer be visiting offices to engage in discussions about opioid products,” the company said, confirming an earlier report by Bloomberg. Doctors and other prescribers who have questions about the drugs will have to contact Purdue’s medical affairs department,...  ", "external_links": [], "published": "2018-02-11T02:06:00.000+02:00", "crawled": "2018-02-11T04:07:07.048+02:00", "highlightTitle": ""}